Clicky

Aquestive Therapeutics, Inc.(AQST) News

Date Title
Jul 22 Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer
Jul 15 Sector Update: Health Care Stocks Mixed Premarket Tuesday
Jul 15 Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film
Jun 25 Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit
May 26 Those who invested in Aquestive Therapeutics (NASDAQ:AQST) three years ago are up 128%
May 14 Aquestive Therapeutics Inc (AQST) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines ...
Apr 14 Strength Seen in Recursion Pharmaceuticals (RXRX): Can Its 27.7% Jump Turn into More Strength?
Feb 13 Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?
Feb 12 Aquestive Therapeutics to Present New Findings on Anaphylm™ (Epinephrine Sublingual Film) at the 2025 AAAAI Annual Meeting
Sep 30 Optimism Around Aquestive As it Moves Forward With Severe Allergy, Baldness Candidate
Sep 27 Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day
Aug 8 Aquestive Therapeutics Second Quarter 2024 Earnings: Beats Expectations
Aug 6 Aquestive Therapeutics (AQST) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Aug 6 Aquestive Therapeutics: Q2 Earnings Snapshot
Jul 30 Institutions profited after Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) market cap rose US$72m last week but retail investors profited the most
Jul 25 Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study
Jul 23 Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET
Jun 25 Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows
Jun 25 Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film
Jun 19 Investors in Aquestive Therapeutics (NASDAQ:AQST) have unfortunately lost 36% over the last five years